Back to top

Image: Bigstock

Slide Insurance Holdings, Inc. (SLDE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Read MoreHide Full Article

Slide Insurance Holdings, Inc. (SLDE - Free Report) reported $347.01 million in revenue for the quarter ended December 2025, representing no change year over year. EPS of $1.23 for the same period compares to $0 a year ago.

The reported revenue represents a surprise of +9.32% over the Zacks Consensus Estimate of $317.42 million. With the consensus EPS estimate being $0.87, the EPS surprise was +41.38%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Slide Insurance Holdings, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Expense Ratio: 29.7% compared to the 26.9% average estimate based on two analysts.
  • Combined Ratio: 38% versus 50.9% estimated by two analysts on average.
  • Loss Ratio: 8.3% versus the two-analyst average estimate of 24%.
  • Revenues- Net investment income: $18.48 million compared to the $15.36 million average estimate based on two analysts.
  • Revenues- Other income: $0.14 million versus the two-analyst average estimate of $0.39 million.
  • Revenues- Net premiums earned: $326.57 million compared to the $299.97 million average estimate based on two analysts.
  • Revenues- Policy fees: $1.82 million versus the two-analyst average estimate of $1.7 million.

View all Key Company Metrics for Slide Insurance Holdings, Inc. here>>>

Shares of Slide Insurance Holdings, Inc. have returned +5.3% over the past month versus the Zacks S&P 500 composite's -1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Zacks' 7 Best Strong Buy Stocks (New Research Report)

Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free

Published in